Mortality News and Research

RSS

Controlling antibiotic-prescribing practices in hospitals

Plenty of promising strategies exist to control antibiotic-prescribing practices, but no single method emerges as the best for hospital patients, according to a new review of studies.

18 Oct 2005

Radical prostatectomy may be a safe option for the treatment of prostate cancer

Prostate cancer is the most common non-skin cancer in American men and the third most common cause of cancer death. In patients with localized disease, radical prostatectomy is associated with lower disease-specific mortality, lower rates of local progression and metastases, and higher overall survival compared with conservative management.

18 Oct 2005

Atypical antipsychotic drugs slightly increase risk for death when used in people with dementia

Atypical antipsychotic drugs seem to confer a small increased risk for death when used in people with dementia, concludes a team of researchers from the Keck School of Medicine of the University of Southern California in a meta-analysis of 15 clinical trials published in the October 19 issue of the JAMA: The Journal of the American Medical Association.

18 Oct 2005

No credible evidence behind claims of harm from the MMR vaccination

There was no credible evidence behind claims of harm from the MMR vaccination. This is the conclusion drawn by the Cochrane Review Authors, an international team of researchers, after carefully drawing together all of the evidence found in 31 high quality studies from around the world.

18 Oct 2005

Beta blockers not as effective as other drugs that reduce high blood pressure in patients with hypertension

Beta blockers are not as effective as other drugs that reduce high blood pressure in patients with hypertension, concludes a meta-analysis published online by The Lancet.

18 Oct 2005

Breath-analysis testing may prove to be an effective method for detecting the damaging lung-bacteria growth seen in cystic fibrosis

By using a chemical analysis method developed for air-pollution testing, UCI chemists and pediatricians have found that people with cystic fibrosis exhale higher concentrations of sulfur compounds from their lungs than do people who don't have the disease.

17 Oct 2005

Researchers identify biomarker that indicates a more agressive form of prostate cancer

Staging factors for prostate cancer such as PSA and the Gleason score are extremely useful in predicting prostate cancer outcome," explained Pollack. "However, new biomarkers hold promise in strengthening our ability to predict response to treatment. By identifying the more virulent forms of prostate cancer, we may be able to tailor treatment or develop therapies to target the abnormalities identified."

17 Oct 2005

Gastric bypass surgery may not be the most effective surgery in producing weight loss

"Overall, we found that patients who elect to have duodenal switch end up slimmer than those who choose gastric bypass," says Dr. Gladys W. Strain, director of research for bariatric surgery at NewYork-Presbyterian/Weill Cornell and associate research professor of nutrition in surgery at Weill Medical College of Cornell University.

16 Oct 2005

Ethnic differences in cardiovascular risk factors

Heredity plays a major role in determining the blood lipid profile and heart rate variability of blacks and whites, two major risk factors for coronary artery disease, researchers say.

16 Oct 2005

High blood pressure is higher in many Asian countries than in Australia

A new study on risk factors in cardiovascular disease in Asia has found that blood pressure is more strongly related to coronary heart disease and stroke in Asia, as compared with Western countries such as Australia and New Zealand.

16 Oct 2005

Aggressive management of diabetes with diet, exercise, and medications may improve the survival of cancer patients

Researchers at Fox Chase Cancer Center found no effects of type II diabetes on aggressiveness of prostate cancer but found that long-term survival is worse. The findings were presented at the 47th Annual Meeting of the American Society for Therapeutic Radiology and Oncology in Denver, Colo.

16 Oct 2005

Liver services in the United Kingdom need better funding and better staffing

Mortality from liver disease is increasing in the UK. In 2000 liver disease killed more men than Parkinson's disease and more women than cancer of the cervix. Deaths from alcoholic liver disease has doubled in the past 10 years, while liver disease arising from hepatitis C infection is expected to treble by 2020.

13 Oct 2005

Lowering infant's body temperature within the first six hours of life reduces the chances for disability

Lowering an infant's body temperature to about 92 degrees Fahrenheit within the first six hours of life reduces the chances for disability and death among infants who failed to receive enough oxygen or blood to the brain during birth. The research study findings appear in tomorrow's 2005 New England Journal of Medicine.

12 Oct 2005

Very low LDL cholesterol levels appear to be safe for heart patients on statin therapies

"There was no apparent safety concern for patients whose resultant LDL on intensive therapy was lower than current guidelines. There was a trend toward improved clinical outcomes in the lowest LDL groups," said Stephen D. Wiviott, M.D., from Brigham and Women's Hospital in Boston, Massachusetts.

11 Oct 2005

Top 12 health issues facing Australian children

Alarming levels of poorer health within indigenous children and those from lower socio-economic backgrounds tops a new list of 12 major issues threatening the future health of Australia.

10 Oct 2005

Colorectal cancer screening rates remain low

Investigators failed to see improvement in colorectal cancer (CRC) screening rates among patients enrolled in a managed care health plan after testing the effectiveness of a CRC screening promotion program targeting the physician organizations (POs).

10 Oct 2005

Actos reduces the combined risk of non-fatal heart attacks, strokes in patients with type-2 diabetes

A study published in The Lancet shows that Takeda's Actos (pioglitazone HCl), an oral glucose lowering medication, significantly reduces the combined risk of non-fatal heart attacks, strokes and deaths by an additional 16% on top of standard medication

10 Oct 2005

Mortality News and Research

Controlling antibiotic-prescribing practices in hospitals

Radical prostatectomy may be a safe option for the treatment of prostate cancer

Atypical antipsychotic drugs slightly increase risk for death when used in people with dementia

No credible evidence behind claims of harm from the MMR vaccination

Beta blockers not as effective as other drugs that reduce high blood pressure in patients with hypertension

Breath-analysis testing may prove to be an effective method for detecting the damaging lung-bacteria growth seen in cystic fibrosis

Researchers identify biomarker that indicates a more agressive form of prostate cancer

Gastric bypass surgery may not be the most effective surgery in producing weight loss

Ethnic differences in cardiovascular risk factors

High blood pressure is higher in many Asian countries than in Australia

Aggressive management of diabetes with diet, exercise, and medications may improve the survival of cancer patients

Liver services in the United Kingdom need better funding and better staffing

Lowering infant's body temperature within the first six hours of life reduces the chances for disability

Very low LDL cholesterol levels appear to be safe for heart patients on statin therapies

Top 12 health issues facing Australian children

Colorectal cancer screening rates remain low

Actos reduces the combined risk of non-fatal heart attacks, strokes in patients with type-2 diabetes

Preventing Chronic Diseases: A Vital Investment

Long-term use of NSAIDs cuts the risk for oral cancer in smokers by half but increases risk of cardiovascular problems

Avian influenza and the U.S

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News